
201 - 500 employees
Founded 2020
🧬 Biotechnology
🤖 Artificial Intelligence
💊 Pharmaceuticals
💰 $370M Series B on 2021-11
Biotechnology • Artificial Intelligence • Pharmaceuticals
Generate Biomedicines is a pioneering therapeutics company that stands at the intersection of machine learning, biological engineering, and medicine. They are leading the development of generative biology, a groundbreaking approach that uses artificial intelligence to create novel medicines with specific therapeutic functions. By studying millions of proteins, Generate Biomedicines has discovered generalizable rules by which nature encodes function, enabling them to generate medicines on demand across multiple therapeutic modalities. Their innovative platform promises to fundamentally change the way medicines are made, expanding technical possibilities and improving speed and success rates in drug discovery.
🕒 April 23
🍂 Massachusetts – Remote
💵 $281k - $422k / year
⏰ Full Time
🟠 Senior
👔 Vice President
🦅 H1B Visa Sponsor
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2020
🧬 Biotechnology
🤖 Artificial Intelligence
💊 Pharmaceuticals
💰 $370M Series B on 2021-11
Biotechnology • Artificial Intelligence • Pharmaceuticals
Generate Biomedicines is a pioneering therapeutics company that stands at the intersection of machine learning, biological engineering, and medicine. They are leading the development of generative biology, a groundbreaking approach that uses artificial intelligence to create novel medicines with specific therapeutic functions. By studying millions of proteins, Generate Biomedicines has discovered generalizable rules by which nature encodes function, enabling them to generate medicines on demand across multiple therapeutic modalities. Their innovative platform promises to fundamentally change the way medicines are made, expanding technical possibilities and improving speed and success rates in drug discovery.
• Leads a high performing Respiratory Product Strategy Team (RPST) comprised of cross-functional leaders accountable for setting the strategy for the late stage respiratory programs • Develops high quality, ambitious development plans for asthma and COPD programs, aligned with late-stage and corporate objectives and compliant with all relevant regulations • Recruits, mentors and develops a team of late-stage clinicians and scientists • Collaborates with Head of Safety and PV to define risk-benefit profiles • Collaborates with Clinical operations and CRO to deliver study to timelines and budget • Oversees protocol development and clinical/scientific content for regulatory submissions and interactions • Provides medical leadership and awareness of evolving external landscape for late-stage clinical trials in respiratory diseases (asthma, COPD) • Drives development and refinement of Target Product Profiles (TPPs), Target Product Claims, and clinical development strategies • Oversee protocol development, study design, medical review of data, and safety monitoring • Serve as the primary medical contact for clinical sites, investigators, and regulatory bodies • Guide interactions with external stakeholders including KOLs, advisory boards, and CROs • Represent Generate externally at scientific, medical, and regulatory meetings
• MD or PhD required; MD strongly preferred • Board certification in Pulmonology or Allergy and Immunology, or Rheumatology preferred • 10+ years of drug development experience in the biopharma industry • Deep expertise in respiratory diseases (asthma, COPD) and late-stage clinical trials • Recent BLA submission experience • Demonstrated success in leading pivotal global studies and regulatory interactions • Strong analytical, communication, and cross-functional leadership skills • Proven ability to influence internal and external stakeholders, including investigators and health authorities.
• Annual bonus • Equity compensation • Competitive benefits package
Apply Now